Skip to main content
PMC home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1982 Nov;50(2):239–245.

Natural killer cells and interferon responses in patients with systemic lupus erythematosus.

G C Tsokos, A H Rook, J Y Djeu, J E Balow
PMCID: PMC1536692  PMID: 6817954

Abstract

Natural killer (NK) cell activity was studied in 23 patients with systemic lupus erythematosus (SLE). The overall NK activity was lower in patients with SLE than in normal female individuals. Patients with clinically active SLE disease had slightly lower NK activity than the patients with inactive disease. Other clinical parameters as well as treatment status did not correlate with NK activity. Interferon (IFN) enhanced the NK activity of normal individuals and of 11 SLE patients, while it did not enhance in the remaining 12 patients. The patients whose NK activity was enhanced by beta-IFN had significantly higher initial activity than those who did not respond to beta-IFN. Furthermore, peripheral mononuclear cells (MNC) from IFN responders produced gamma-IFN after stimulation with concanavalin A (Con A) in titres comparable to those of normals. In contrast, peripheral MNC from beta-IFN non-responders failed to produce significant titres of gamma-IFN after stimulation with Con A. These results indicate that certain patients with SLE have low NK activity, which is generally paralleled by an inability to respond to exogenous beta-IFN and by blunted production of gamma-IFN after stimulation with Con A.

Full text

PDF
242

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Canoso J. J., Cohen A. S. Malignancy in a series of 70 patients with systemic lupus erythematosus. Arthritis Rheum. 1974 Jul-Aug;17(4):383–390. doi: 10.1002/art.1780170407. [DOI] [PubMed] [Google Scholar]
  2. Charpentier B., Carnaud C., Bach J. F. Selective depression of the xenogeneic cell-mediated lympholysis in systemic lupus erythematosus. J Clin Invest. 1979 Aug;64(2):351–360. doi: 10.1172/JCI109469. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Djeu J. Y., Heinbaugh J. A., Holden H. T., Herberman R. B. Augmentation of mouse natural killer cell activity by interferon and interferon inducers. J Immunol. 1979 Jan;122(1):175–181. [PubMed] [Google Scholar]
  4. Feldmann J. L., Becker M. J., Moutsopoulos H., Fye K., Blackman M., Epstein W. V., Talal N. Antibody-dependent cell-mediated cytotoxicity in selected autoimmune diseases. J Clin Invest. 1976 Jul;58(1):173–179. doi: 10.1172/JCI108447. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Gershwin M. E., Glinski W., Chused T., Steinberg A. D. Lymphocyte-dependent antibody-mediated cytolysis of DNA-anti-DNA-coated target cells using human and murine SLE effector populations. Clin Immunol Immunopathol. 1977 Sep;8(2):280–291. doi: 10.1016/0090-1229(77)90118-0. [DOI] [PubMed] [Google Scholar]
  6. Goto M., Tanimoto K., Horiuchi Y. Natural cell mediated cytotoxicity in systemic lupus erythematosus: suppression by antilymphocyte antibody. Arthritis Rheum. 1980 Nov;23(11):1274–1281. doi: 10.1002/art.1780231108. [DOI] [PubMed] [Google Scholar]
  7. Green J. A., Dawson A. A., Walker W. Systemic lupus erythematosus and lymphoma. Lancet. 1978 Oct 7;2(8093):753–756. doi: 10.1016/s0140-6736(78)92645-4. [DOI] [PubMed] [Google Scholar]
  8. Hoffman T. Natural killer funciton in systemic lupus erythematosus. Arthritis Rheum. 1980 Jan;23(1):30–35. doi: 10.1002/art.1780230106. [DOI] [PubMed] [Google Scholar]
  9. Kadish A. S., Doyle A. T., Steinhauer E. H., Ghossein N. A. Natural cytotoxicity and interferon production in human cancer: deficient natural killer activity and normal interferon production in patients with advanced disease. J Immunol. 1981 Nov;127(5):1817–1822. [PubMed] [Google Scholar]
  10. Kiessling R., Haller O. Natural killer cells in the mouse: an alternative immune surveillance mechanism? Contemp Top Immunobiol. 1978;8:171–201. doi: 10.1007/978-1-4684-0922-2_6. [DOI] [PubMed] [Google Scholar]
  11. Minato N., Reid L., Cantor H., Lengyel P., Bloom B. R. Mode of regulation of natural killer cell activity by interferon. J Exp Med. 1980 Jul 1;152(1):124–137. doi: 10.1084/jem.152.1.124. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Neighbour P. A., Grayzel A. I. Interferon production of vitro by leucocytes from patients with systemic lupus erythematosus and rheumatoid arthritis. Clin Exp Immunol. 1981 Sep;45(3):576–582. [PMC free article] [PubMed] [Google Scholar]
  13. Oshimi K., Gonda N., Sumiya M., Kano S. Effects of corticosteroids on natural killer cell activity in systemic lupus erythematosus. Clin Exp Immunol. 1980 Apr;40(1):83–88. [PMC free article] [PubMed] [Google Scholar]
  14. Ruíz-Argüelles A., Díaz-Jouanen E., Alarcón-Segovia D. PHA-induced cellular cytotoxicity. Inhibition by a nonimmunoglobulin factor present in sera from patients with active systemic lupus erythematosus. Arthritis Rheum. 1979 Jan;22(1):59–65. doi: 10.1002/art.1780220109. [DOI] [PubMed] [Google Scholar]
  15. Santoli D., Koprowski H. Mechanisms of activation of human natural killer cells against tumor and virus-infected cells. Immunol Rev. 1979;44:125–163. doi: 10.1111/j.1600-065x.1979.tb00269.x. [DOI] [PubMed] [Google Scholar]
  16. Scheinberg M. A., Cathcart E. S. Antibody-dependent direct cytotoxicity of human lymphocytes. I. Studies on peripheral blood lymphocytes and sera of patients with systemic lupus erythematosus. Clin Exp Immunol. 1976 May;24(2):317–322. [PMC free article] [PubMed] [Google Scholar]
  17. Schneider J., Chin W., Friou G. J., Cooper S. M., Harding B., Hill R. L., Quismorio F. P. Reduced antibody-dependent cell-mediated cytotoxicity in systemic lupus erythematosus. Clin Exp Immunol. 1975 May;20(2):187–192. [PMC free article] [PubMed] [Google Scholar]
  18. Silverman S. L., Cathcart E. S. Natural killing in systemic lupus erythematosus: inhibitory effects of serum. Clin Immunol Immunopathol. 1980 Oct;17(2):219–226. doi: 10.1016/0090-1229(80)90090-2. [DOI] [PubMed] [Google Scholar]
  19. Taurog J. D., Raveche E. S., Smathers P. A., Glimcher L. H., Huston D. P., Hansen C. T., Steinberg A. D. T cell abnormalities in NZB mice occur independently of autoantibody production. J Exp Med. 1981 Feb 1;153(2):221–234. doi: 10.1084/jem.153.2.221. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Trinchieri G., Santoli D. Anti-viral activity induced by culturing lymphocytes with tumor-derived or virus-transformed cells. Enhancement of human natural killer cell activity by interferon and antagonistic inhibition of susceptibility of target cells to lysis. J Exp Med. 1978 May 1;147(5):1314–1333. doi: 10.1084/jem.147.5.1314. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Tsokos G. C., Balow J. E. Cytotoxic responses to alloantigens in systemic lupus erythematosus. J Clin Immunol. 1981 Oct;1(4):208–216. doi: 10.1007/BF00915138. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES